Market closed

Zimmer Biomet/$ZBH

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Zimmer Biomet

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Ticker

$ZBH
Sector
Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies
Headquarters
Warsaw, United States

Employees

18,000
Website
www.zimmerbiomet.com

Zimmer Biomet Metrics

BasicAdvanced
$21B
20.07
$5.26
1.02
$0.96
0.91%

$21B

1.02

$133.90

$100.67

1.5M

$0.96

1.362

0.574

39.29

53.611

18.29%

7.67%

4.61%

8.71%

20.066

2.851

1.7

-17.63

21.837

0.91%

0.91%

4.35%

132.72%

2.10%

10.40%

What the Analysts think about Zimmer Biomet

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Zimmer Biomet stock.

Zimmer Biomet Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Zimmer Biomet Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Zimmer Biomet News

AllArticlesVideos
Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook

Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook

Seeking Alpha·1 week ago
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

MarketBeat·1 month ago
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts

Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts

Benzinga·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ZBH

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jan31
Zimmer Biomet
Dividend·Payment
$0.24
Per share

FAQs

What’s the current market cap for Zimmer Biomet stock?

Zimmer Biomet (ZBH) has a market cap of $21B as of January 15, 2025.

What is the P/E ratio for Zimmer Biomet stock?

The price to earnings (P/E) ratio for Zimmer Biomet (ZBH) stock is 20.07 as of January 15, 2025.

Does Zimmer Biomet stock pay dividends?

Yes, the Zimmer Biomet (ZBH) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.96 and the yield is 0.91%. Zimmer Biomet has a payout ratio of 18.29% on a trailing twelve-month basis.

When is the next Zimmer Biomet dividend payment date?

The next Zimmer Biomet (ZBH) dividend payment is scheduled for January 31, 2025.

What is the beta indicator for Zimmer Biomet?

Zimmer Biomet (ZBH) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.